Home Institutions Mount Sinai clinical trials Institution Directory
Clinical trials at Mount Sinai Sites in New York, NY
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 22, 2026, 8:46 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1097
Current sort
Recently updated
Campus scope
Mount Sinai, New York, NY
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 397–408 of 1,097 matching trials with a site at Mount Sinai, New York, NY.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Diffuse Large B-Cell Lymphoma, Classic Follicular Lymphoma
Interventions Epcoritamab Drug
Lead sponsor Genmab Industry
Eligibility 18 Years and older
Enrollment 184 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2022 – 2027
U.S. locations 70
States / cities Mobile, Alabama • Little Rock, Arkansas • Springdale, Arkansas + 60 more
Conditions Prostate Cancer, Prostatic Neoplasms
Interventions 64Cu-SAR-bisPSMA Drug
Lead sponsor Clarity Pharmaceuticals Ltd Industry
Eligibility 18 Years and older · Male only
Enrollment 383 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2026
U.S. locations 29
States / cities Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 23 more
Conditions Advanced Solid Tumors, HNSCC, SCLC, NSCLC, TNBC - Triple-Negative Breast Cancer, CRC
Interventions TUB-030 Drug
Lead sponsor Gilead Sciences Industry
Eligibility 18 Years and older
Enrollment 250 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2028
U.S. locations 13
States / cities New Haven, Connecticut • Miami, Florida • Boston, Massachusetts + 9 more
Conditions Diffuse Large B-Cell Lymphoma
Interventions Epcoritamab, Cyclophosphamide, Rituximab, Vincristine, Doxorubicin, Prednisone Drug
Lead sponsor Genmab Industry
Eligibility 18 Years to 79 Years
Enrollment 900 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2029
U.S. locations 68
States / cities Tucson, Arizona • Yuma, Arizona • Little Rock, Arkansas + 57 more
Conditions Cancer
Interventions TTX-080, pembrolizumab, cetuximab, FOLFIRI Drug
Lead sponsor Tizona Therapeutics, Inc Industry
Eligibility 18 Years and older
Enrollment 240 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2027
U.S. locations 41
States / cities Tucson, Arizona • Los Angeles, California • Newport Beach, California + 37 more
Conditions B-cell Malignancy, Relapsed Cancer, Refractory Cancer, B-cell Lymphoma
Interventions Tacabrutideg, Sonrotoclax, Zanubrutinib, Mosunetuzumab, Glofitamab, Obinutuzumab Drug
Lead sponsor BeOne Medicines Industry
Eligibility 18 Years and older
Enrollment 80 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2029
U.S. locations 17
States / cities Phoenix, Arizona • Los Angeles, California • Jacksonville, Florida + 11 more
Conditions Prostatic Neoplasms
Interventions 177Lu-PSMA-617, 68Ga-PSMA-11, ARDT Drug
Lead sponsor Novartis Pharmaceuticals Industry
Eligibility 18 Years to 100 Years · Male only
Enrollment 469 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2026
U.S. locations 20
States / cities Denver, Colorado • Gainesville, Florida • New Orleans, Louisiana + 13 more
Conditions Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Interventions [177Lu]Lu-DOTA-TATE, Octreotide LAR Radiation · Drug
Lead sponsor Novartis Pharmaceuticals Industry
Eligibility 12 Years to 100 Years
Enrollment 240 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2034
U.S. locations 20
States / cities Scottsdale, Arizona • Fayetteville, Arkansas • Denver, Colorado + 16 more
Conditions Congenital Heart Disease (CHD)
Interventions Breastfeeding clinical practice guideline (CPG) for congenital heart disease (CHD) Other
Lead sponsor Carelon Research Other
Eligibility 18 Years and older
Enrollment 266 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2030
U.S. locations 17
States / cities Phoenix, Arizona • Los Angeles, California • Aurora, Colorado + 13 more
Conditions Advanced Cancer, Metastatic Cancer, Solid Tumor, Melanoma, Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Anaplastic Thyroid Cancer (ATC)
Interventions JZP815 Drug
Lead sponsor Jazz Pharmaceuticals Industry
Eligibility 18 Years and older
Enrollment 98 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2022 – 2028
U.S. locations 15
States / cities Los Angeles, California • Denver, Colorado • Orlando, Florida + 10 more
Conditions Systemic Lupus Erythematosus (With and Without Nephritis), Idiopathic Inflammatory Myopathy, Systemic Sclerosis
Interventions ALLO-329, Cyclophosphamide, Fludarabine Genetic · Drug
Lead sponsor Allogene Therapeutics Industry
Eligibility 18 Years to 74 Years
Enrollment 66 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2032
U.S. locations 16
States / cities Phoenix, Arizona • Loma Linda, California • Aurora, Colorado + 13 more
Conditions Early Life Adversity, Trauma, Stress
Interventions Cannabidiol, Placebo Drug
Lead sponsor Icahn School of Medicine at Mount Sinai Other
Eligibility 18 Years to 25 Years
Enrollment 160 participants
Healthy volunteers Accepts healthy volunteers
Timeline 2025 – 2030
U.S. locations 1
States / cities New York, New York About this Mount Sinai institution page
What this page lists ClinicalTrials.gov records that list Mount Sinai in New York, NY as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , browse by condition , or browse by U.S. city .